245 related articles for article (PubMed ID: 37452555)
21. Successful treatment of paediatric generalized pustular psoriasis with secukinumab: a case series.
Albela H; Begum S; Leong KF
J Dermatolog Treat; 2022 May; 33(3):1769-1773. PubMed ID: 33706651
[TBL] [Abstract][Full Text] [Related]
22. Generalized pustular psoriasis: the new era of treatment with IL-36 receptor inhibitors.
Maçães CO; Lé AM; Torres T
J Dermatolog Treat; 2022 Nov; 33(7):2911-2918. PubMed ID: 35695278
[TBL] [Abstract][Full Text] [Related]
23. Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis.
Baum P; Visvanathan S; Garcet S; Roy J; Schmid R; Bossert S; Lang B; Bachelez H; Bissonnette R; Thoma C; Krueger JG
J Allergy Clin Immunol; 2022 Apr; 149(4):1402-1412. PubMed ID: 34678325
[TBL] [Abstract][Full Text] [Related]
24. Flare-up of generalized pustular psoriasis combined with systemic capillary leak syndrome after coronavirus disease 2019 mRNA vaccination.
Yatsuzuka K; Murakami M; Kuroo Y; Fukui M; Yoshida S; Muto J; Shiraishi K; Sayama K
J Dermatol; 2022 Apr; 49(4):454-458. PubMed ID: 34862669
[TBL] [Abstract][Full Text] [Related]
25. Adalimumab treatment in Japanese patients with generalized pustular psoriasis: Results of an open-label phase 3 study.
Morita A; Yamazaki F; Matsuyama T; Takahashi K; Arai S; Asahina A; Imafuku S; Nakagawa H; Hasegawa Y; Williams D; Matsuda N; Kitamura S
J Dermatol; 2018 Dec; 45(12):1371-1380. PubMed ID: 30302793
[TBL] [Abstract][Full Text] [Related]
26. Spesolimab for the Treatment of Generalized Pustular Psoriasis.
Bernardo D; Thaçi D; Torres T
Drugs; 2024 Jan; 84(1):45-58. PubMed ID: 38114719
[TBL] [Abstract][Full Text] [Related]
27. Current management of generalized pustular psoriasis.
Kodali N; Blanchard I; Kunamneni S; Lebwohl MG
Exp Dermatol; 2023 Aug; 32(8):1204-1218. PubMed ID: 36779681
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of hospitalizations and emergency department visits due to generalized pustular psoriasis in the United States.
Hanna ML; Singer D; Bender SD; Valdecantos WC; Wu JJ
Curr Med Res Opin; 2021 Oct; 37(10):1697-1703. PubMed ID: 34289766
[TBL] [Abstract][Full Text] [Related]
29. Childhood generalized pustular psoriasis: Successful long-term treatment with adalimumab.
Hansel K; Marietti R; Tramontana M; Bianchi L; Romita P; Giuffrida R; Stingeni L
Dermatol Ther; 2020 May; 33(3):e13294. PubMed ID: 32134546
[No Abstract] [Full Text] [Related]
30. Clinical characteristics and heterogeneity of generalized pustular psoriasis: A comparative study in a large retrospective cohort.
Xu Z; Liu Y; Qu H; Bai Y; Ma J; Hao J; Yu C; Dang E; Wang G; Shao S
Exp Dermatol; 2024 Jan; 33(1):e14891. PubMed ID: 37493071
[TBL] [Abstract][Full Text] [Related]
31. Biologic therapies associated with development of palmoplantar pustulosis and palmoplantar pustular psoriasis: a systematic review.
Lu JD; Lytvyn Y; Mufti A; Zaaroura H; Sachdeva M; Kwan S; Abduelmula A; Kim P; Yeung J
Int J Dermatol; 2023 Jan; 62(1):12-21. PubMed ID: 35128653
[TBL] [Abstract][Full Text] [Related]
32. Acrodermatitis continua of Hallopeau and generalised pustular psoriasis: Should they be the same or different entities?
Chularojanamontri L; Rattanakorn K; Julanon N; Chuamanochan M; Griffiths CEM
Exp Dermatol; 2023 Aug; 32(8):1235-1245. PubMed ID: 37057764
[TBL] [Abstract][Full Text] [Related]
33. A brief guide to pustular psoriasis for primary care providers.
Crowley JJ; Pariser DM; Yamauchi PS
Postgrad Med; 2021 Apr; 133(3):330-344. PubMed ID: 33118424
[TBL] [Abstract][Full Text] [Related]
34. Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.
Menter A; Van Voorhees AS; Hsu S
Dermatol Ther (Heidelb); 2021 Dec; 11(6):1917-1929. PubMed ID: 34626330
[TBL] [Abstract][Full Text] [Related]
35. Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis.
Morita A; Choon SE; Bachelez H; Anadkat MJ; Marrakchi S; Zheng M; Tsai TF; Turki H; Hua H; Rajeswari S; Thoma C; Burden AD
Dermatol Ther (Heidelb); 2023 Jan; 13(1):347-359. PubMed ID: 36333618
[TBL] [Abstract][Full Text] [Related]
36. Generalized pustular psoriasis in a toddler with IL36RN mutation: a case report.
Adi G; Shaath MR; Adi K; Obaid Z; Aldosari E; AlKateb FA
Front Immunol; 2024; 15():1337799. PubMed ID: 38571950
[TBL] [Abstract][Full Text] [Related]
37. Incidence and prevalence of generalized pustular psoriasis in multiethnic Johor Bahru, Malaysia: a population-based cohort study using routinely captured electronic health records in the Teleprimary Care (TPC®) clinical information system from 2010 to 2020.
Choon SE; Wright AK; Griffiths CEM; Wong KW; Tey KE; Lim YT; Chua KY; Ashcroft DM
Br J Dermatol; 2023 Sep; 189(4):410-418. PubMed ID: 37162007
[TBL] [Abstract][Full Text] [Related]
38. Pustular drug eruption due to bacampicilin hydrochloride in a patient with psoriasis.
Isogai Z; Sunohara A; Tsuji T
J Dermatol; 1998 Sep; 25(9):612-5. PubMed ID: 9798349
[TBL] [Abstract][Full Text] [Related]
39. The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab.
Hawkes JE; Visvanathan S; Krueger JG
Front Immunol; 2023; 14():1292941. PubMed ID: 38077370
[TBL] [Abstract][Full Text] [Related]
40. Generalized pustular psoriasis is a disease distinct from psoriasis vulgaris: evidence and expert opinion.
Bachelez H; Barker J; Burden AD; Navarini AA; Krueger JG
Expert Rev Clin Immunol; 2022 Oct; 18(10):1033-1047. PubMed ID: 36062811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
